Immunoprophylaxis and immunotherapy for a murine fibrosarcoma with C. Granulosum and C. Parvum

Luka Milas, Jordan U. Gutterman, Ivan Bašić, Nancy Hunter, Giora M. Mavligit, Evan M. Hersh, H. Rodney Withers

Research output: Contribution to journalArticlepeer-review

41 Scopus citations

Abstract

Prophylactic and therapeutic effectiveness of killed C. granulosum and C. parvum bacteria was investigated against a methylcholanthrene‐induced fibrosarcoma in syngeneic C3Hf/Bu mice. Subcutaneous or intravenous treatment of mice with 0.25 mg of these bacteria greatly reduced the number of tumor nodules (metastases, colonies) in the lung generated by 105 or 106 fibrosarcoma cells inoculated intravenously 7 days later. The treatment also prolonged the survival of tumor‐cell recipients, and to some mice afforded complete protection against tumor growth. Number of lung metastases and survival of the recipients were more affected by intravenous than by subcutaneous treatment with the bacteria. Given intravenously to mice 3 days after intravenous inoculation of 2×105 fibrosarcoma cells, these non‐specific immunostimulants significantly reduced the number of pulmonary colonies and prolonged survival of mice. In contrast, subcutaneous application of the bacteria was only slightly effective. Both C. granulosum and C. parvum administered intravenously to mice 3 days following subcutaneous injection of 4×105 fibrosarcoma cells did not affect the development of subcutaneous tumors. However, when the tumors had grown to 25‐17 mm in diameter 67% and 80% of them underwent complete and lasting regressions in mice treated with C. granulosum and C. parvum, respectively. C. granulosum and C. parvum were approximately equally effective against both intravenously and subcutaneously injected tumor cells.

Original languageEnglish (US)
Pages (from-to)493-503
Number of pages11
JournalInternational Journal of Cancer
Volume14
Issue number4
DOIs
StatePublished - Oct 15 1974

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Immunoprophylaxis and immunotherapy for a murine fibrosarcoma with C. Granulosum and C. Parvum'. Together they form a unique fingerprint.

Cite this